Study protocol: The development of a pilot study employing a randomised controlled design to investigate the feasibility and effects of a peer support program following discharge from a specialist first-episode psychosis treatment centre
- Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia: Four Decades of Experience. Kindermann, S.S.; Dolder, C.R.; Bailey, A.; Katz, I.R.; Jeste, D.V. // Drugs & Aging;2002, Vol. 19 Issue 4, p257
A number of studies, using different research designs and assessment instruments, have been conducted to elucidate the differential effects of drug treatments for psychosis, agitation and aggression in elderly patients with dementia. We have reviewed literature published from 1960 to 2000 on...
- Synthetic Cannabis-Induced Mania. Ustundag, Mehmet Fatih; Ozhan Ibis, Esra; Yucel, Atakan; Ozcan, Halil // Case Reports in Psychiatry;3/9/2015, Vol. 2015, p1
Synthetic cannabinoids (SC), cannabinoid 1 and cannabinoid 2 receptors agonists, are the psychoactive substances. SC was originally produced to treat medical conditions. Compared to other narcotics, SC is easier to obtain, cheap, and highly potent and has a long half-life. In addition, routine...
- pseudodementia. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1921
A definition of the medical term "pseudodementia," which refers to an impairment in thinking marked by withdrawal from social interactions that results from depression, is presented.
- Dementia and its implications for the practice nurse. Robinson, Francesca // Practice Nurse;7/24/2009, Vol. 38 Issue 2, p10
The article resents an overview of dementia and of the role that nurse practitioners can play in managing patients that have dementia. A discussion of the case of Barbara Pointon, a British nurse practitioner who lost her husband to dementia, is presented. Advances which have been made in the...
- Future management options. Barker, Andy; Benbow, Susan // Pulse;4/26/2004, Vol. 64 Issue 17, p46
Discusses management options for behavioral and psychiatric symptoms in dementia in elder patients in Great Britain. Management of older patients already taking olanzapine or risperidone; Treatment of people who have dementia and psychosis, such as paranoid delusions.
- Social network among young adults with first-episode schizophrenia spectrum disorders. Thorup, Anne; Petersen, Lone; Jeppesen, Pia; Øhlenschlæger, Johan; Christensen, Torben; Krarup, Gertrud; Jørgensen, Per; Nordentoft, Merete // Social Psychiatry & Psychiatric Epidemiology;Oct2006, Vol. 41 Issue 10, p761
Social network has considerable impact on physical and mental health. Patients experiencing first-episode psychosis early in adult life may experience severe problems concerning development and maintenance of their social network. A total of 547 first-episode psychotic patients (18â€“45)...
- Let's get our teens moving in B.C. // South Asian Post;3/19/2015, p9
No abstract available.
- Are antipsychotics antipsychotics? Steinert, Tilman; Jandl, Martin // Psychopharmacology;Oct2010, Vol. 212 Issue 1, p117
The article examines the viability of antipsychotic drugs, formerly called as neuroleptics, in treating schizophrenia, mania, bipolar depression and other psychotic states. It suggests that antipsychotics are psychoactive drugs with antipsychotic and several other properties instead of having a...
- Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide. Badawy, Abdulla // Psychopharmacology;Aug2013, Vol. 228 Issue 3, p347
Rationale: Current amino acid (AA) mixtures used in acute tryptophan (Trp) and tyrosine (Tyr) plus phenylalanine (Phe) depletion and loading tests are unpalatable and lack specificity. Specificity is improved by reducing content of branched-chain amino acids (BCAA) and palatability to a certain...